Seeking Alpha

Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma...

Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma treatment. Shares +6.9% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector